Plas Laboratory

Publications

2023

Shin, Sejeong; Han, Min-Joon; Jedrychowski, Mark P; Zhang, Ziyang; Shokat, Kevan M; Plas, David R; Dephoure, Noah; Yoon, Sang-Oh 2023. mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching. Cell reports, 42 8, 112868

Garrett, Matthew C; Albano, Rebecca; Carnwath, Troy; Elahi, Lubayna; Behrmann, Catherine A; Pemberton, Merissa; Woo, Daniel; O'Brien, Eric; VanCauwenbergh, Brett; Perentesis, John; Shah, Sanjit; Hagan, Matthew; Kendler, Ady; Zhao, Chuntao; Paranjpe, Aditi; Roskin, Krishna; Kornblum, Harley; Plas, David R; Lu, Q Richard 2023. HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma. Scientific reports, 13 1, 12433

Verma, Rita; Aggarwal, Parul; Bischoff, Megan E; Reigle, James; Secic, Dina; Wetzel, Collin; VandenHeuvel, Katherine; Biesiada, Jacek; Ehmer, Birgit; Landero Figueroa, Julio A; Plas, David R; Medvedovic, Mario; Meller, Jarek; Czyzyk-Krzeska, Maria F 2023. Microtubule-associated protein MAP1LC3C regulates lysosomal exocytosis and induces zinc reprogramming in renal cancer cells. The Journal of biological chemistry, 299 5, 104663

2022

Karve, Aniruddha S; Desai, Janki M; Dave, Nimita; Wise-Draper, Trisha M; Gudelsky, Gary A; Phoenix, Timothy N; DasGupta, Biplab; Sengupta, Soma; Plas, David R; Desai, Pankaj B 2022. Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole. Cancer chemotherapy and pharmacology, 90 4, 345-356

Garrett, Matthew C; Albano, Rebecca; Carnwath, Troy; Shah, Sanjit; Woo, Daniel; Lamba, Michael; Plas, David R; Paranjpe, Aditi; Roskin, Krishna; Zhao, Chuntao; Lu, Richard 2022. Chromatin structure predicts survival in glioma patients. Scientific reports, 12 1, 8221